Discover how quality-driven drug development and AI accelerate safer medicines, reduce risk, and improve patient outcomes.

Cancer drug development has never moved faster. Yet, for too many patients, the next treatment decision still begins with ...

There has been much discussion recently about how artificial intelligence and machine learning (AI/ML) will revolutionize pharmaceutical research. Substantial progress has been made in the discovery ...

In this week’s edition of InnovationRx, we look at a new AI drug development deal, a pill for sleep apnea, Commure’s $7 billion valuation, and more.

Researchers are increasingly using AI to accelerate the search for treatments for neurological conditions such as Alzheimer’s ...

Developing a new medication can cost over $1 billion, depending on the drug’s complexity and expenses accrued via unsuccessful studies. Considering these costs, an optimized regulatory process is ...

AstraZeneca CEO Pascal Soriot said AI is helping the company develop medicines faster and make smarter decisions throughout ...

Adequate representation of study populations in low- and middle-income countries in global anticancer drug development trials is critical to develop affordable and accessible cancer care with optimal ...

Experience the forefront of pharmaceutical innovation as Labroots and the Drug Discovery and Development planning committee host the 9th Annual Drug Discovery & Development Virtual Event on February ...